Recognition of an Extraordinary Loss (Impairment Loss on Shares of an Affiliate) in Non-Consolidated Financial Results
GMOインターネットグループ株式会社 and its consolidated subsidiary, GMO-Z.com Trust Company, Inc.
GMO-Z.com Trust Company, Inc. (U.S. entity), the Japanese yen-linked stablecoin GYEN, and the U.S. dollar-linked stablecoin ZUSD
The decision was made to liquidate the U.S. entity in anticipation of future business expansion in Japan, following the acquisition of technical expertise relating to stablecoins.
¥2.2 billion (impairment loss on shares of an affiliate, recognized as an extraordinary loss, in the non-consolidated financial results)
Non-consolidated financial results for the second quarter of the fiscal year ending December 2026
The impact on consolidated results is expected to be minor.
Related procedures
Liquidation proceedings in accordance with applicable local laws
New York State Department of Financial Services (NYDFS)
The liquidation proceedings will be conducted in consultation with the New York State Department of Financial Services. In the fourth quarter, the amount of the impairment loss on shares of an affiliate recognized on this occasion may change depending on the market value of the shares. If any matter requiring disclosure arises, it will be disclosed promptly.
| Item | Details |
|---|---|
| Event name | Recognition of an Extraordinary Loss (Impairment Loss on Shares of an Affiliate) in Non-Consolidated Financial Results |
| Date of occurrence | 15 May 2026 (the date the Board of Directors resolved to dissolve and liquidate GMO Trust) |
| Subject Entity | GMOインターネットグループ株式会社 and its consolidated subsidiary, GMO-Z.com Trust Company, Inc. |
| Target Locations / Products | GMO-Z.com Trust Company, Inc. (U.S. entity), the Japanese yen-linked stablecoin GYEN, and the U.S. dollar-linked stablecoin ZUSD |
| Cause | The decision was made to liquidate the U.S. entity in anticipation of future business expansion in Japan, following the acquisition of technical expertise relating to stablecoins. |
| Amount of Impact on Business Performance | ¥2.2 billion (impairment loss on shares of an affiliate, recognized as an extraordinary loss, in the non-consolidated financial results) |
| Accounting period in which recognized | Non-consolidated financial results for the second quarter of the fiscal year ending December 2026 |
| Impact on Earnings Forecast | The impact on consolidated results is expected to be minor. |
| Type of litigation or proceeding | Liquidation proceedings in accordance with applicable local laws |
| Court or authority | New York State Department of Financial Services (NYDFS) |
| Date of filing / date of action | 15 May 2026 (the date of the resolution to dissolve and liquidate the entity) |
| Outlook | The liquidation proceedings will be conducted in consultation with the New York State Department of Financial Services. In the fourth quarter, the amount of the impairment loss on shares of an affiliate recognized on this occasion may change depending on the market value of the shares. If any matter requiring disclosure arises, it will be disclosed promptly. |
| Planned follow-up disclosure | If any matter requiring disclosure arises, it will be disclosed promptly. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The U.S. entity will be liquidated in anticipation of future business expansion in Japan, following the acquisition of technical expertise relating to stablecoins.